Intermediate to advanced hepatocellular carcinoma
Conditions
Interventions
Observation group:None
Sponsors
The First Hospital of Nanchang
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age >= 18 years; 2. Generally in good condition, ECOG PS 0-1; 3. Clinically or pathologically diagnosed with hepatocellular carcinoma according to the "Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)"; 4. At least one measurable lesion on imaging; 5. Liver function Child-Pugh class A or B; 6. No significant abnormalities in peripheral blood white blood cells and platelets in laboratory tests; 7. Informed consent from the patient.
Exclusion criteria
Exclusion criteria: 1. Combined severe dysfunction of other major organs such as heart, lungs, brain, or kidneys, accompanied by severe infection or systemic disease; 2. Liver function Child-Pugh class C, or ECOG PS score >=2; 3. Presence of other malignant tumors; 4. History of allergy to related drugs; 5. Contraindications to TACE or HAIC; 6. Incomplete follow-up data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Antitumor Efficacy and Adverse Reactions; | — |
Countries
China
Contacts
Public ContactZeng Guangzheng
The First Hospital of Nanchang
Outcome results
None listed